Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update / Fenaux P; Mufti GJ; Hellström-Lindberg E; Santini V; Gattermann N; Sanz G; List AF; Gore SD; Seymour JF; Backstrom J; Zimmerman L; McKenzie D; Beach CL; Silverman LB.. - In: ECANCERMEDICALSCIENCE. - ISSN 1754-6605. - STAMPA. - 2:(2008), pp. 121-121.
Azacitidine prolongs overall survival and reduces infections and hospitalizations in patients with WHO-defined acute myeloid leukaemia compared with conventional care regimens: an update.
SANTINI, VALERIA;
2008
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ecancermanuscript.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
290.31 kB
Formato
Adobe PDF
|
290.31 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
